| Ms Nova Dev Sweet, LCSW | |
|
445 3rd Ave Sw, Albany, OR 97321-2272 | |
| (541) 967-3866 | |
| Not Available |
| Full Name | Ms Nova Dev Sweet |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 445 3rd Ave Sw, Albany, Oregon |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356427827 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | L7705 (Oregon) | Primary |
| Entity Name | County Of Linn |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760575781 PECOS PAC ID: 7911984638 Enrollment ID: O20040701000264 |
News Archive
Using two drugs that inhibit the growth factor HER2 for preoperative treatment of early-stage HER2-positive breast cancer appears to have better results than treatment with a single agent. In a report in the January 17 issue of The Lancet, an international research team reports that a protocol adding lapatinib (Tykerb) to trastuzumab (Herceptin) was more effective than single-drug treatment with either drug in eliminating microscopic signs of cancer at the time the tumors were surgically removed.
Secretary of State Hillary Rodham Clinton delivered a major speech today to mark the 15th anniversary of the International Conference on Population and Development (ICPD). Her strong message showed top-level U.S. Government support for the ICPD and other such UN goals, including the Millennium Development Goals, by 2015.
As obesity is fast overtaking tobacco as the leading risk factor for heart disease, a new laboratory for studying the biology of fat cells (adipocytes) is opening its doors at the Henderson Research Centre.
Nanomaterials found in consumer and health-care products can pass from the bloodstream to the brain side of a blood-brain barrier model with varying ease depending on their shape - creating potential neurological impacts that could be both positive and negative, a new study reveals.
A new study of nearly 8,800 women with early-stage breast cancer found that fewer than half - approximately 49 percent - completed their full regimen of hormone therapy according to the prescribed schedule.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Nova Dev Sweet, LCSW 445 3rd Ave Sw, Albany, OR 97321-2272 Ph: (541) 967-3866 | Ms Nova Dev Sweet, LCSW 445 3rd Ave Sw, Albany, OR 97321-2272 Ph: (541) 967-3866 |
News Archive
Using two drugs that inhibit the growth factor HER2 for preoperative treatment of early-stage HER2-positive breast cancer appears to have better results than treatment with a single agent. In a report in the January 17 issue of The Lancet, an international research team reports that a protocol adding lapatinib (Tykerb) to trastuzumab (Herceptin) was more effective than single-drug treatment with either drug in eliminating microscopic signs of cancer at the time the tumors were surgically removed.
Secretary of State Hillary Rodham Clinton delivered a major speech today to mark the 15th anniversary of the International Conference on Population and Development (ICPD). Her strong message showed top-level U.S. Government support for the ICPD and other such UN goals, including the Millennium Development Goals, by 2015.
As obesity is fast overtaking tobacco as the leading risk factor for heart disease, a new laboratory for studying the biology of fat cells (adipocytes) is opening its doors at the Henderson Research Centre.
Nanomaterials found in consumer and health-care products can pass from the bloodstream to the brain side of a blood-brain barrier model with varying ease depending on their shape - creating potential neurological impacts that could be both positive and negative, a new study reveals.
A new study of nearly 8,800 women with early-stage breast cancer found that fewer than half - approximately 49 percent - completed their full regimen of hormone therapy according to the prescribed schedule.
› Verified 1 days ago
Tanya R Thompson, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 445 3rd Ave Sw, Albany, OR 97321 Phone: 541-967-3866 Fax: 541-928-3020 | |
John Corbett Caster, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 630 4th Ave Se, Albany, OR 97321 Phone: 541-254-0158 | |
Malia P. Delohery-dart, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2730 Pacific Blvd Se, Albany, OR 97321 Phone: 541-967-3866 Fax: 541-672-7146 | |
Mick Fredrickson, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 425 2nd Ave Sw Ste 102, Albany, OR 97321 Phone: 541-286-3209 Fax: 541-704-0040 | |
Rosa E Plascencia, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 734 Elm St Sw, Albany, OR 97321 Phone: 541-812-5111 | |
Janet Spencer, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 400 Hickory St Nw Ste 100, Albany, OR 97321 Phone: 541-812-5880 | |
Meghan West, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2730 Pacific Blvd Se, Albany, OR 97321 Phone: 541-967-3866 |